Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China
· Delayed Price · Currency is CNY 3.430
+0.070 (2.08%)
Apr 29, 2026, 3:04 PM CST
SHE:300026 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 10,304 | 10,575 | 11,386 | 12,738 | 17,064 | 23,523 | Upgrade
|
| Market Cap Growth | -4.19% | -7.12% | -10.61% | -25.35% | -27.46% | 70.96% | Upgrade
|
| Enterprise Value | 9,403 | 9,968 | 11,349 | 13,109 | 18,344 | 24,054 | Upgrade
|
| Last Close Price | 3.43 | 3.52 | 3.76 | 4.17 | 5.56 | 7.61 | Upgrade
|
| PE Ratio | 275.33 | 571.75 | 530.38 | 25.14 | 27.34 | 34.22 | Upgrade
|
| Forward PE | - | 16.83 | 16.83 | 16.83 | 16.83 | 16.83 | Upgrade
|
| PS Ratio | 2.20 | 2.14 | 1.97 | 2.09 | 2.57 | 3.07 | Upgrade
|
| PB Ratio | 1.18 | 1.22 | 1.29 | 1.44 | 2.02 | 2.96 | Upgrade
|
| P/TBV Ratio | 1.34 | 1.39 | 1.48 | 1.66 | 2.36 | 3.49 | Upgrade
|
| P/FCF Ratio | 15.06 | 15.53 | 17.27 | 10.77 | - | - | Upgrade
|
| P/OCF Ratio | 12.90 | 13.03 | 13.36 | 8.32 | 22.89 | 60.07 | Upgrade
|
| PEG Ratio | - | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | Upgrade
|
| EV/Sales Ratio | 2.01 | 2.02 | 1.96 | 2.15 | 2.76 | 3.14 | Upgrade
|
| EV/EBITDA Ratio | 14.26 | 15.48 | 29.32 | 16.23 | 18.83 | 19.77 | Upgrade
|
| EV/EBIT Ratio | 25.26 | 27.56 | 110.81 | 25.43 | 25.32 | 24.00 | Upgrade
|
| EV/FCF Ratio | 13.74 | 14.64 | 17.22 | 11.08 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.06 | 0.10 | 0.17 | 0.25 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 0.82 | 0.82 | 1.95 | 1.78 | 2.03 | 1.55 | Upgrade
|
| Debt / FCF Ratio | 0.78 | 0.78 | 1.29 | 1.30 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.11 | -0.11 | -0.05 | 0.00 | 0.11 | 0.08 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.51 | -1.51 | -1.17 | -0.05 | 0.91 | 0.53 | Upgrade
|
| Net Debt / FCF Ratio | -1.43 | -1.43 | -0.69 | -0.03 | -35.48 | -2.27 | Upgrade
|
| Asset Turnover | 0.46 | 0.46 | 0.50 | 0.50 | 0.55 | 0.70 | Upgrade
|
| Inventory Turnover | 1.32 | 1.32 | 1.51 | 1.35 | 1.61 | 2.40 | Upgrade
|
| Quick Ratio | 3.21 | 3.21 | 2.57 | 2.89 | 1.79 | 2.46 | Upgrade
|
| Current Ratio | 4.46 | 4.46 | 3.79 | 4.29 | 2.76 | 3.31 | Upgrade
|
| Return on Equity (ROE) | 0.26% | 0.26% | 0.26% | 5.79% | 7.57% | 8.74% | Upgrade
|
| Return on Assets (ROA) | 2.10% | 2.10% | 0.56% | 2.63% | 3.73% | 5.75% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.24% | 1.21% | 0.51% | 4.69% | 7.00% | 9.83% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.00% | 4.00% | 1.10% | 5.00% | 7.30% | 10.50% | Upgrade
|
| Earnings Yield | 0.23% | 0.18% | 0.19% | 3.98% | 3.66% | 2.92% | Upgrade
|
| FCF Yield | 6.64% | 6.44% | 5.79% | 9.29% | -0.15% | -1.21% | Upgrade
|
| Dividend Yield | 0.89% | - | 0.80% | 0.72% | 0.54% | 0.53% | Upgrade
|
| Payout Ratio | 430.60% | 569.87% | 638.70% | 30.53% | 30.56% | 22.96% | Upgrade
|
| Buyback Yield / Dilution | 13.85% | 13.84% | 27.97% | -0.26% | 0.53% | 0.98% | Upgrade
|
| Total Shareholder Return | 14.74% | 13.84% | 28.76% | 0.46% | 1.07% | 1.50% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.